| Tadalafil Mylan 20 mg film-coated tablets EU/1/14/961/002-006 |
Tadalafil |
Mylan Pharmaceuticals Limited |
— |
| Tadalafil Mylan 5 mg film-coated tablets EU/1/14/961/012-017 |
Tadalafil |
Mylan Pharmaceuticals Limited |
— |
| Tafinlar 50 mg hard capsules EU/1/13/865/001-002 |
Dabrafenib |
Novartis Europharm Limited |
— |
| Tafinlar 75 mg hard capsules EU/1/13/865/003-004 |
Dabrafenib |
Novartis Europharm Limited |
— |
| TAGRISSO 40 mg film-coated tablets EU/1/16/1086/001 |
Osimertinib mesylate |
AstraZeneca AB |
— |
| TAGRISSO 80 mg film-coated tablets EU/1/16/1086/002 |
Osimertinib mesylate |
AstraZeneca AB |
— |
| TAKHZYRO 150 mg solution for injection in pre-filled syringe EU/1/18/1340/007-009 |
LANADELUMAB |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| TAKHZYRO 300 mg solution for injection EU/1/18/1340/001 |
LANADELUMAB |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Talmanco 20 mg film-coated tablets EU/1/16/1153/001-004 |
Tadalafil |
Viatris Limited |
— |
| Taltz 40mg Solution for injection EU/1/15/1085/007 |
Ixekizumab |
Eli Lilly Kinsale Limited |
— |
| Taltz 80 mg solution for injection in pre-filled pen EU/1/15/1085/001-003 |
Ixekizumab |
Eli Lilly Kinsale Limited |
— |
| Taltz 80 mg solution for injection in pre-filled syringe EU/1/15/1085/004-006 |
Ixekizumab |
Eli Lilly Kinsale Limited |
— |
| TALVEY 2 mg/mL solution for injection EU/1/23/1748/001 |
Talquetamab |
Janssen-Cilag International NV |
— |
| TALVEY 40 mg/mL solution for injection EU/1/23/1748/002 |
Talquetamab |
Janssen-Cilag International NV |
— |
| Talzenna 0.1 mg Capsule, hard EU/1/19/1377/007 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Talzenna 0.25 mg Capsule, hard EU/1/19/1377/001-004 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Talzenna 0.35 mg hard capsules EU/1/19/1377/008 |
Talazoparib tosilate |
Advanz Pharma Limited |
— |
| Talzenna 0.5 mg hard capsules EU/1/19/1377/009 |
Talazoparib tosilate |
Pfizer Europe MA EEIG |
— |
| Talzenna 1 mg Capsule, hard EU/1/19/1377/005-006 |
TALAZOPARIB TOSYLATE |
Pfizer Europe MA EEIG |
— |
| Tamiflu 30 mg hard capsules EU/1/02/222/003 |
Oseltamivir |
Roche Registration GmbH |
— |
| Tamiflu 45 mg hard capsules EU/1/02/222/004 |
Oseltamivir |
Roche Registration GmbH |
— |
| Tamiflu 6 mg/ml powder for oral suspension EU/1/02/222/005 |
Oseltamivir phosphate |
Roche Registration GmbH |
— |
| Tamiflu 75 mg hard capsules EU/1/02/222/001 |
Oseltamivir phosphate |
Roche Registration GmbH |
— |
| Tamsulosin Rowa 400 microgram modified-release hard capsules PA0074/101/001 |
Tamsulosin hydrochloride |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Tandemact EU/1/06/366/005-16 |
Glimepiride, Pioglitazone |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Tandemact EU/1/06/366/17-22 |
Glimepiride, Pioglitazone hydrochloride |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Tapentadol MSN 100 mg prolonged-release tablets PA23250/009/003 |
Tapentadol tartrate |
MSN Labs Europe Limited |
Not marketed |
| Tapentadol MSN 150 mg prolonged-release tablets PA23250/009/004 |
Tapentadol tartrate |
MSN Labs Europe Limited |
Not marketed |
| Tapentadol MSN 200 mg prolonged-release tablets PA23250/009/005 |
Tapentadol tartrate |
MSN Labs Europe Limited |
Not marketed |
| Tapentadol MSN 25 mg prolonged-release tablets PA23250/009/001 |
Tapentadol tartrate |
MSN Labs Europe Limited |
Not marketed |
| Tapentadol MSN 250 mg prolonged-release tablets PA23250/009/006 |
Tapentadol tartrate |
MSN Labs Europe Limited |
Not marketed |
| Tapentadol MSN 50 mg prolonged-release tablets PA23250/009/002 |
Tapentadol tartrate |
MSN Labs Europe Limited |
Not marketed |
| Tarceva 100mg film-coated tablets EU/1/05/311/002 |
Erlotinib hydrochloride |
Cheplapharm Registration GmbH |
— |
| Tarceva 150 mg film-coated tablets EU/1/05/311/003 |
Erlotinib hydrochloride |
Cheplapharm Registration GmbH |
— |
| Tarceva 25 mg film-coated tablets EU/1/05/311/001 |
Erlotinib hydrochloride |
Cheplapharm Registration GmbH |
— |
| Targin 10mg/5mg prolonged-release tablets PA1688/010/002 |
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Targin 15 mg/7.5 mg prolonged-release tablets PA1688/010/006 |
OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Targin 20mg/10mg prolonged-release tablets PA1688/010/003 |
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Targin 30 mg/15 mg prolonged-release tablets PA1688/010/007 |
OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Targin 40 mg/20 mg prolonged-release tablets PA1688/010/004 |
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Targin 5 mg/2.5 mg prolonged-release tablets PA1688/010/001 |
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Targretin 75 mg soft capsules EU/1/01/178/001 |
Bexarotene |
H.A.C Pharma |
— |
| Tasigna 150 mg Capsule, hard EU/1/07/422/005-006 |
Nilotinib |
Novartis Europharm Limited |
— |
| Tasigna 200 mg Capsule, hard EU/1/07/422/001-004 |
Nilotinib |
Novartis Europharm Limited |
— |
| Tasigna 50 mg Capsule, hard EU/1/07/422/015 |
Nilotinib |
Novartis Europharm Limited |
— |
| Tasmar 100 mg film-coated tablets EU/1/97/044/001 |
Tolcapone |
Viatris Healthcare Limited |
— |
| Tasmar 100 mg film-coated tablets EU/1/97/044/002 |
Tolcapone |
Viatris Healthcare Limited |
— |
| Tasmar 100 mg film-coated tablets EU/1/97/044/003 |
Tolcapone |
Viatris Healthcare Limited |
— |
| Tasmar 200 mg film-coated tablets EU/1/97/044/004 |
Tolcapone |
Viatris Healthcare Limited |
— |
| Tasmar 200 mg film-coated tablets EU/1/97/044/005 |
Tolcapone |
Viatris Healthcare Limited |
— |